Home » BARR PREPARED TO SATISFY FTC REQUIREMENTS FOR POTENTIAL ACQUISITION OF PLIVA D.D.
BARR PREPARED TO SATISFY FTC REQUIREMENTS FOR POTENTIAL ACQUISITION OF PLIVA D.D.
Barr Pharmaceuticals, Inc. announced that it is prepared to satisfy any requirements that the U.S. Federal Trade Commission (FTC) might impose regarding the Company's proposed tender offer to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. Consequently, the company will not include an FTC approval condition
in the formal tender offer it intends to file with the Croatian Financial Services
Supervisory Agency (HANFA) later this week.
Drug
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May